Ontology highlight
ABSTRACT: Background
Identification of wound-specific markers would represent an important step toward damaged tissue detection and targeted delivery of biologically important materials to injured sites. Such delivery could minimize the amount of therapeutic materials that must be administered and limit potential collateral damage on nearby normal tissues. Yet, biological markers that are specific for injured tissue sites remain elusive.Methods
In this study, we have developed an immunohistological approach for identification of protein epitopes specifically exposed in wounded tissue sites.Results
Using ex-vivo tissue samples in combination with fluorescently-labeled antibodies we show that actin, an intracellular cytoskeletal protein, is specifically exposed upon injury. The targetability of actin in injured sites has been demonstrated in vivo through the specific delivery of anti-actin conjugated particles to the wounded tissue in a lethal rat model of grade IV liver injury.Conclusions
These results illustrate that identification of injury-specific protein markers and their targetability for specific delivery is feasible.General significance
Identification of wound-specific targets has important medical applications as it could enable specific delivery of various products, such as expression vectors, therapeutic drugs, hemostatic materials, tissue healing, or scar prevention agents, to internal sites of penetrating or surgical wounds regardless of origin, geometry or location.
SUBMITTER: Pendleton ED
PROVIDER: S-EPMC5613279 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature
Pendleton Erik D ED Sullivan Challise J CJ Sasmor Henri H HH Bruse Kristy D KD Mayfield Tifanie B TB Valente David L DL Abrams Rachel E RE Griffey Richard H RH Dresios John J
Biochemistry and biophysics reports 20160518
<h4>Background</h4>Identification of wound-specific markers would represent an important step toward damaged tissue detection and targeted delivery of biologically important materials to injured sites. Such delivery could minimize the amount of therapeutic materials that must be administered and limit potential collateral damage on nearby normal tissues. Yet, biological markers that are specific for injured tissue sites remain elusive.<h4>Methods</h4>In this study, we have developed an immunohis ...[more]